These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35181483)

  • 41. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.
    Reddy VY; Holmes D; Doshi SK; Neuzil P; Kar S
    Circulation; 2011 Feb; 123(4):417-24. PubMed ID: 21242484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Watchman FLX Device: First European Experience and Feasibility of Intracardiac Echocardiography to Guide Implantation.
    Korsholm K; Samaras A; Andersen A; Jensen JM; Nielsen-Kudsk JE
    JACC Clin Electrophysiol; 2020 Dec; 6(13):1633-1642. PubMed ID: 33334441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up.
    Phillips KP; Pokushalov E; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
    Europace; 2018 Jun; 20(6):949-955. PubMed ID: 29106523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of the new generation Watchman FLX device compared to the Watchman 2.5: a systematic review and meta-analysis.
    Najim M; Reda Mostafa M; Eid MM; Alabdouh A; Awad AK; Elbanna M; Mohamed S; Alweis R; Al-Azizi KM; Mamas MA
    Am J Cardiovasc Dis; 2023; 13(5):291-299. PubMed ID: 38026111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Left atrial appendage closure device implantation in patients at very high risk for stroke.
    Hutt E; Wazni OM; Kaur S; Saliba WI; Tarakji KG; Kapadia S; Aguilera J; Barakat AF; Abdallah M; Jaber W; Rasmussen P; Hussain S; Uchino K; Wisco D; Lindsay BD; Kanj M; Hussein AA
    Heart Rhythm; 2020 Jan; 17(1):27-32. PubMed ID: 31302250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Computed Tomography Scan Evidence for Left Atrial Appendage Short-Term Remodeling Following Percutaneous Occlusion: Impact of Device Oversizing.
    Mahmoudi K; Galea R; Elhadad S; Temperli F; Sebag F; Gräni C; Rezine Z; Roten L; Landolff Q; Brugger N; Masri A; Räber L; Amabile N
    J Am Heart Assoc; 2023 Sep; 12(17):e030037. PubMed ID: 37609989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EWOLUTION: Design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology.
    Boersma LV; Schmidt B; Betts TR; Sievert H; Tamburino C; Teiger E; Stein KM; Bergmann MW
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):460-5. PubMed ID: 26719158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P
    J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
    Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device.
    Enomoto Y; Gadiyaram VK; Gianni C; Horton RP; Trivedi C; Mohanty S; Di Biase L; Al-Ahmad A; Burkhardt JD; Narula A; Janczyk G; Price MJ; Afzal MR; Atoui M; Earnest M; Swarup V; Doshi SK; van der Zee S; Fisher R; Lakkireddy DR; Gibson DN; Natale A; Reddy VY
    Heart Rhythm; 2017 Jan; 14(1):19-24. PubMed ID: 27771552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Left atrial appendage occlusion in patients older than 85 years. Safety and efficacy in the EWOLUTION registry.
    Cruz-González I; Ince H; Kische S; Schmitz T; Schmidt B; Gori T; Foley D; de Potter T; Tschishow W; Vireca E; Stein K; Boersma LV
    Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):21-27. PubMed ID: 30956034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry.
    Daimee UA; Wang Y; Masoudi FA; Varosy PD; Friedman DJ; Du C; Koutras C; Reddy VY; Saw J; Price MJ; Kusumoto FM; Curtis JP; Freeman JV
    Circ Cardiovasc Qual Outcomes; 2022 Aug; 15(8):e008418. PubMed ID: 35959677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining left atrial appendage closure and catheter ablation for atrial fibrillation: 2-year outcomes from a multinational registry.
    Phillips KP; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
    Europace; 2020 Feb; 22(2):225-231. PubMed ID: 31665276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy.
    Pracon R; Bangalore S; Dzielinska Z; Konka M; Kepka C; Kruk M; Kaczmarska-Dyrda E; Petryka-Mazurkiewicz J; Bujak S; Solecki M; Pskit A; Dabrowska A; Sieradzki B; Plonski A; Ruzyllo W; Witkowski A; Demkow M
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005997. PubMed ID: 29463510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.
    Ledwoch J; Franke J; Gonzaga M; Bertog S; Braut A; Hofmann I; Vaskelyte L; Gafoor S; Reddy V; Sievert H
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):787-94. PubMed ID: 26354821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Computed tomography measurement of the left atrial appendage for optimal sizing of the Watchman device.
    Xu B; Betancor J; Sato K; Harb S; Abdur Rehman K; Patel K; Kumar A; Cremer PC; Jaber W; Rodriguez LL; Schoenhagen P; Wazni O
    J Cardiovasc Comput Tomogr; 2018; 12(1):50-55. PubMed ID: 29223726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical outcomes of Watchman vs. Amplatzer occluders for left atrial appendage closure (WATCH at LAAC).
    Kleinecke C; Yu J; Neef P; Buffle E; de Marchi S; Fuerholz M; Nietlispach F; Valgimigli M; Streit SR; Fankhauser M; Duenninger E; Windecker S; Meier B; Gloekler S
    Europace; 2020 Jun; 22(6):916-923. PubMed ID: 32003774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.